logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Kidney Stone Market, By Product (Dranage Tube, Guidewires, Sheath Dialators, Cathetors, Others), By End User (Hospital, Ambulatory Surgical Center, Emergency Facilities) opportunities and forecast 2020-2027

  • DLR2170
  • 20 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Growing cases of the kidney stone disorder, increase in the demand for Minimally Invasive Surgical (MIS) procedures, and augmented awareness about product are few factors propelling the market. According to study published in the National Center for the Biotechnology Information (NCBI), the urolithiasis affects almost 12% of world population.

In addition, almost 13% of men and around 7% of the women develop the kidney stone during their life. Nephrostomy devices support in restoring the urine flow over blocked ureters and return kidney to normal function. Growing popularity of various minimally invasive processes is further driving the market growth. Moreover, rising cases of the lifestyle-related disorders are expected to contribute to market expansion. Improving healthcare structure in the developing economies is also prompting the global market.

Segment Overview

Guidewires segment is anticipated to hold the maximum share of market during the forecast period due to non-invasive nature of product. Rising elderly population, and the prevalence of bladder and urinary disorders are anticipated to increase demand for the product, thus influencing growth of the segment.

The companies of guidewire are concentrating on collaborations with healthcare practitioners to rise their customer base and also, to strengthen their presence in industry. Henceforth, such initiatives by manufacturers and the presence of well-established and experienced practitioners in developed economies is anticipated to increase demand for guidewires. Technological progressions in devices, such as institution of balloon dilation catheter with the original multilayer technology, are further expected to offer the lucrative opportunities to market.

Regional Overview

North America dominated the global market in 2019. It is anticipated to witness considerable growth in the future as well owing to favourable reimbursement policies, growing awareness for the product, accessibility of highly experienced physicians, and the presence of well-established facilities in the region. Furthermore, quick adoption of the technologically advanced products is anticipated to drive market in region. Growing funding by the government for R&D actions in the surgical devices and the procedures is further positively affecting the North America market growth.
Asia Pacific is anticipated to grow at highest CAGR from 2020 to 2026 due to growing cases of the kidney disorders, government initiatives, and numerous programs by the NGOs to raise consciousness about product. Moreover, incidence of large number of the key companies in India and India is further contributing to market growth. Rapidly growing medical tourism market in emerging economies of APAC is further anticipated to boost product demand, thus augmenting market growth.

Competitor overview

The company’s focus more on the new product development, the technological advancements, and mergers and acquisition to strengthen their position in global market. For instance, Cook Medical launched Universa, in Feb 2019, with two sets of percutaneous urinary drainage. The product includes ureteral stents and foley catheters in different conformation and sizes to meet specific references and the needs of patients and physician.

Key Players
  1. Teleflex, Inc.;
  2. Cardinal Health;
  3. Becton, Dickinson and Company;
  4. Cook Medical;
  5. B. Braun Melsungen AG;
  6. Coloplast Group;
  7. Olympus Corp.;
  8. Argon Medical;
  9. Uresil LLC.
  10. Boston Scientific

Market Segmentation
By Product
  • Guidewires
  • Nephrostomy Catheters
  • Drainage Tubes
  • Sheath Dilators
  • Others
By End User
  • Emergency Clinics
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 11

    2 Introduction 13

    • 2.1 Definition 13
    • 2.2 Scope of Study 13
    • 2.3 Research Objective 13
    • 2.4 Assumptions & Limitations 13
      • 2.4.1 Assumptions 13
      • 2.4.2 Limitations 13
    • 2.5 Market Structure 14

    3 Research Methodology 15

    • 3.1 Primary Research 16
    • 3.2 Secondary Research 16

    4 Market Dynamics 17

    • 4.1 Introduction 17
    • 4.2 Drivers 17
      • 4.2.1 Minimally invasive procedures for treatment of kidney stones has boosted market growth 17
      • 4.2.2 Increasing Incidence Of Urolithiasis In The Adult Population 18
      • 4.2.3 Poor Nutrition Driving Rise In Kidney Stones Market 18
    • 4.3 Restraints 18
      • 4.3.1 Adverse effects of Extracorporeal shock wave lithotripsy 18
    • 4.4 Opportunity 19
      • 4.4.1 Advance medications for kidney treatment 19

    5 Market Factor Analysis 20

    • 5.1 Porters Five Forces Model 20
      • 5.1.1 Bargaining Power of Suppliers 21
      • 5.1.2 Bargaining Power of Buyers 21
      • 5.1.3 Threat of New Entrants 21
      • 5.1.4 Threat of Substitutes 21
      • 5.1.5 Intensity of Rivalry 22
    • 5.2 Value Chain Analysis 22
      • 5.2.1 Research & Product development 22
      • 5.2.2 Manufacturing 23
      • 5.2.3 Distribution 23
      • 5.2.4 Marketing & Sales 23
      • 5.2.5 Post-Sales Services 23

    6 Global Kidney Stones Market, By Types 24

    • 6.1 Introduction 24
    • 6.2 Calcium Stones 25
    • 6.3 Uric Acid 26
    • 6.4 Struvite Kidney Stones 28
    • 6.5 Cystine stones 28

    7 Global Kidney Stones Market, By Treatment Types 30

    • 7.1 Introduction 30
    • 7.2 Medications 31
    • 7.3 Extracorporeal Shock Wave Lithotripsy (ESWL) 32
    • 7.4 Ureteroscopy (URS) 32
    • 7.5 Percutaneous nephrolithotomy (PCNL) 33

    8 Global Kidney Stone Market, By Diagnosis 35

    • 8.1 Introduction 35
    • 8.2 Ultrasound 37
    • 8.3 Intravenous Pyelography (IVP) or Intravenous Urogram 38
    • 8.4 CT Scan 39
    • 8.5 X-ray 40

    9 Global Kidney Stone Market, By Region 41

    • 9.1 Introduction 41
    • 9.2 North America 43
      • 9.2.1 US 45
      • 9.2.2 Canada 48
    • 9.3 Europe 50
      • 9.3.1 Germany 52
      • 9.3.2 France 54
      • 9.3.3 U.K 56
      • 9.3.4 Italy 57
      • 9.3.5 Spain 59
      • 9.3.6 Rest of Europe 60
    • 9.4 Asia Pacific 63
      • 9.4.1 China 65
      • 9.4.2 Japan 67
      • 9.4.3 India 69
      • 9.4.4 Republic of Korea 70
      • 9.4.5 Australia 72
      • 9.4.6 Rest of Asia Pacific 74
    • 9.5 Middle East & Africa 77
      • 9.5.1 UAE 80
      • 9.5.2 Saudi Arabia 82
      • 9.5.3 Egypt 84
      • 9.5.4 Rest of Middle east & africa 86

    10 Competitive Landscape 89

      11 Company Profiles 90

      • 11.1 Boston Scientific Corporation 90
        • 11.1.1 Company Overview 90
        • 11.1.2 Product/Business Segment Overview 90
        • 11.1.3 Financial Overview 91
        • 11.1.4 Key Development 91
        • 11.1.5 DLR Analysis 92
      • 11.2 Convergent Laser Technologies 93
        • 11.2.1 Company Overview 93
        • 11.2.2 Product/Business Segment Overview 93
        • 11.2.3 Financial Overview 93
        • 11.2.4 Key Development 93
        • 11.2.5 MRFR Analysis 93
      • 11.3 DirexGroup 94
        • 11.3.1 Company Overview 94
        • 11.3.2 Product/Business Segment Overview 94
        • 11.3.3 Financial Overview 94
        • 11.3.4 Key Development 94
        • 11.3.5 DLR Analysis 94
      • 11.4 Siemens Healthcare GmbH 95
        • 11.4.1 Company Overview 95
        • 11.4.2 Product/Business Segment Overview 95
        • 11.4.3 Financial Overview 95
        • 11.4.4 Key Development 96
        • 11.4.5 DLR Analysis 97
      • 11.5 C.R. Bard Inc. 98
        • 11.5.1 Overview 98
        • 11.5.2 Product Overview 98
        • 11.5.3 Financials 98
        • 11.5.4 Key Developments 99
        • 11.5.5 DLR Analysis 99
      • 11.6 Cook Medical Inc. 100
        • 11.6.1 Overview 100
        • 11.6.2 Product Overview 100
        • 11.6.3 Financials 100
        • 11.6.4 Key Developments 101
        • 11.6.5 DLR Analysis 101
      • 11.7 Dornier MedTech GmbH 102
        • 11.7.1 Overview 102
        • 11.7.2 Product Overview 102
        • 11.7.3 Financials 102
        • 11.7.4 Key Developments 102
        • 11.7.5 DLR Analysis 103
      • 11.8 Richard Wolf Medical Instruments Corporation 104
        • 11.8.1 Overview 104
        • 11.8.2 Product Overview 104
        • 11.8.3 Financials 104
        • 11.8.4 DLR Analysis 104
      • 11.9 Olympus Corporation 105
        • 11.9.1 Overview 105
        • 11.9.2 Product Overview 105
        • 11.9.3 Financials 106
        • 11.9.4 Key Developments 106
        • 11.9.5 DLR Analysis 107
      • 11.10 Stryker Corporation 108
        • 11.10.1 Overview 108
        • 11.10.2 Product overview 108
        • 11.10.3 Financials 108
        • 11.10.4 Key Developments 109

      Report You Might be Interested